MicroRNA-29 regulates high-glucose-induced apoptosis in human retinal pigment epithelial cells through PTEN

[1]  F. Cipollone,et al.  Role of microRNAs in the modulation of diabetic retinopathy , 2014, Progress in Retinal and Eye Research.

[2]  T. Kundu,et al.  High-glucose-induced CARM1 expression regulates apoptosis of human retinal pigment epithelial cells via histone 3 arginine 17 dimethylation: role in diabetic retinopathy. , 2014, Archives of biochemistry and biophysics.

[3]  S. Sivaprasad,et al.  Diabetic retinopathy: pathogenesis, clinical grading, management and future developments , 2013, Diabetic medicine : a journal of the British Diabetic Association.

[4]  K. Sakagami,et al.  PTEN regulates retinal interneuron morphogenesis and synaptic layer formation , 2012, Molecular and Cellular Neuroscience.

[5]  A. Harel-Bellan,et al.  Expression and cellular localization of microRNA-29b and RAX, an activator of the RNA-dependent protein kinase (PKR), in the retina of streptozotocin-induced diabetic rats , 2011, Molecular vision.

[6]  Arunmozhiarasi Armugam,et al.  MicroRNA 144 Impairs Insulin Signaling by Inhibiting the Expression of Insulin Receptor Substrate 1 in Type 2 Diabetes Mellitus , 2011, PloS one.

[7]  Shunbin Xu,et al.  MicroRNAs in early diabetic retinopathy in streptozotocin-induced diabetic rats. , 2011, Investigative ophthalmology & visual science.

[8]  Min Xu,et al.  Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study , 2011, Acta Diabetologica.

[9]  Xiyan Li,et al.  mTOR-mediated dedifferentiation of the retinal pigment epithelium initiates photoreceptor degeneration in mice. , 2011, The Journal of clinical investigation.

[10]  N. Raghavachari,et al.  MicroRNA expression in human retinal pigment epithelial (ARPE-19) cells: Increased expression of microRNA-9 by N-(4-Hydroxyphenyl)retinamide , 2010, Molecular vision.

[11]  Cristina Hernández,et al.  The Retinal Pigment Epithelium: Something More than a Constituent of the Blood-Retinal Barrier—Implications for the Pathogenesis of Diabetic Retinopathy , 2010, Journal of biomedicine & biotechnology.

[12]  T. Mak,et al.  Retinal degeneration triggered by inactivation of PTEN in the retinal pigment epithelium. , 2008, Genes & development.

[13]  Jin-Wu Nam,et al.  Genomics of microRNA. , 2006, Trends in genetics : TIG.

[14]  D. Bartel.  MicroRNAs Genomics, Biogenesis, Mechanism, and Function , 2004, Cell.

[15]  M. Sulis,et al.  PTEN: from pathology to biology. , 2003, Trends in cell biology.

[16]  P. Burger,et al.  Pten regulates neuronal soma size: a mouse model of Lhermitte-Duclos disease , 2001, Nature Genetics.

[17]  K. Hoang-Xuan,et al.  Targeting mutants of PTEN reveal distinct subsets of tumour suppressor functions. , 2001, The Biochemical journal.

[18]  J. Winer,et al.  Development and validation of real-time quantitative reverse transcriptase-polymerase chain reaction for monitoring gene expression in cardiac myocytes in vitro. , 1999, Analytical biochemistry.

[19]  H. Ahsan.  Diabetic retinopathy--biomolecules and multiple pathophysiology. , 2015, Diabetes & metabolic syndrome.

[20]  Wei Shen,et al.  Altered microRNA expression profiles in retinas with diabetic retinopathy. , 2012, Ophthalmic research.

[21]  P. Campochiaro,et al.  Cellular mechanisms of blood-retinal barrier dysfunction in macular edema , 2004, Documenta Ophthalmologica.